[1]
|
J. Folkman, E. Merler, C. Abernathy and G. Williams, “Isolation of a Tumor Factor Responsible for Angiogenesis,” Journal of Experimental Medicine, Vol. 133, No. 2, 1971, pp. 275-288. doi:10.1084/jem.133.2.275
|
[2]
|
P. Wachsberger, R. Burd and A. P. Dicker, “Tumor Response to Ionizing Radiation Combined with Antiangiogenesis or Vascular Targeting Agents: Exploring Mechanisms of Interaction,” Clinical Cancer Research, Vol. 9, No. 6, 2003, pp. 1957-1971.
|
[3]
|
Y. Cao, R. Cao and N. Veitonmaki, “Kringle Structures and Antiangiogenesis,” Current Medicinal Chemistry— Anti-Cancer Agents, Vol. 2, No. 6, 2002, pp. 667-681.
doi:10.2174/1568011023353705
|
[4]
|
D. J. Davidson, C. Haskell, S. Majest, A. Kherzai, D. A. Egan, K. A. Walter, et al., “Kringle 5 of Human Plasminogen Induces Apoptosis of Endothelial and Tumor Cells through Surface-Expressed Glucose-Regulated Protein 78,” Cancer Research, Vol. 65, No. 11, 2005, pp. 4663-4672. doi:10.1158/0008-5472.CAN-04-3426
|
[5]
|
L. Bello, C. Giussani, G. Carrabba, M. Pluderi, F. Costa and A. Bikfalvi, “Angiogenesis and Invasion in Gliomas,” Cancer Treatment and Research, Vol. 117, 2004, pp. 263-284. doi:10.1007/978-1-4419-8871-3_16
|
[6]
|
G.-H. Jin, D.-Y. Ma, N. Wu, F. M. M. T. Marikar, S.-Z. Jin, W.-W. Jiang, et al., “Combination of Human Plasminogen Kringle 5 with Ionizing Radiation Significantly Enhances the Efficacy of Antitumor Effect,” International Journal of Cancer, Vol. 121, No. 11, 2007, pp. 2539-2546. doi:10.1002/ijc.22708
|
[7]
|
M. M. Ahmed, “Regulation of Radiation-Induced Apoptosis by Early Growth Response-1 Gene in Solid Tumors,” Current Cancer Drug Targets, Vol. 4, No. 1, 2004, pp. 43-52. doi:10.2174/1568009043481704
|
[8]
|
O. Greco, B. Marples, G. U. Dachs, K. J. Williams, A. V. Patterson and S. D. Scott, “Novel Chimeric Gene Promoters Responsive to Hypoxia and Ionizing Radiation,” Gene Therapy, Vol. 9, No. 20, 2002, pp. 1403-1411.
doi:10.1038/sj.gt.3301823
|
[9]
|
M. Y. Wu, X. Y. Wu, Q. S. Li and R. M. Zheng, “Expression of Egr-1 Gene and Its Correlation with the Oncogene Proteins in Non-Irradiated and Irradiated Esophageal Squamous Cell Carcinoma,” Diseases of the Esophagus, Vol. 19, No. 4, 2006, pp. 267-272.
doi:10.1111/j.1442-2050.2006.00575.x
|
[10]
|
H. B. Ma, X. J. Wang, Z. L. Di, H. Xia, Z. Li, J. Liu, et al., “Construction of Targeted Plasmid Vector pcDNA3.1-Egr.1p-p16 and Its Expression in Pancreatic Cancer JF305 Cells Induced by Radiation in Vitro,” World Journal of Gastroenterology, Vol. 13, No. 31, 2007, pp. 4214-4218.
|
[11]
|
N. Khalighinejad, H. Hariri, O. Behnamfar, A. Yousefi and A. Momeni, “Adenoviral Gene Therapy in Gastric Cancer: A Review,” World Journal of Gastroenterology, Vol. 14, No. 2, 2008, pp. 180-184.
doi:10.3748/wjg.14.180
|
[12]
|
F. M. Boyce and N. L. Bucher, “Baculovirus-Mediated Gene Transfer into Mammalian Cells,” Proceedings of the National Academy of Sciences USA, Vol. 93, No. 6, 1996, pp. 2348-2352. doi:10.1073/pnas.93.6.2348
|
[13]
|
H. Matilainen, J. Rinne, L. Gilbert, V. Marjomaki, H. Reunanen and C. Oker-Blom, “Baculovirus Entry into Human Hepatoma Cells,” Journal of Virology, Vol. 79, No. 24, 2005, pp. 15452-15459.
doi:10.1128/JVI.79.24.15452-15459.2005
|
[14]
|
D. L. Jarvis and A. Garcia Jr., “Long-Term Stability of Baculoviruses Stored under Various Conditions,” Biotechniques, Vol. 16, 1994, pp. 508-513.
|
[15]
|
W. Huang, X. L. Tian, Y. L. Wu, J. Zhong, L. F. Yu, S. P. Hu, et al., “Suppression of Gastric Cancer Growth by Baculovirus Vectormediated Transfer of Normal Epithelial Cell Specific-1 Gene,” World Journal of Gastroenterology, Vol. 14, No. 38, 2008, pp. 5810-5815.
doi:10.3748/wjg.14.5810
|
[16]
|
R. Guo, Y. F. Zhang, S. Liang, H. P. Xu, M. Zhang and B. Li, “Sodium Butyrate Enhances the Expression of Baculovirus-Mediated Sodium/Iodide Symporter Gene in A549 Lung Adenocarcinoma Cells,” Nuclear Medicine Communications, Vol. 31, No. 10, 2010, pp. 916-921.
|
[17]
|
J. M. McLoughlin, T. M. McCarty, C. Cunningham, V. Clark, N. Senzer, J. Nemunaitis, et al., “TNFerade, an Adenovector Carrying the Transgene forHuman Tumor Necrosis Factor a, for Patients with Advanced Solid Tumors: Surgical Experience and Long-Term Follow-Up,” Annals of Surgical Oncology, Vol.12, No.10, 2005, pp. 825-830. doi:10.1245/ASO.2005.03.023
|
[18]
|
R. P. Dings, B. W. Williams, C. W. Song, A. W. Griffioen, K. H. Mayo and R. J. Griffin, “Anginex Synergizes with Radiation Therapy to Inhibit Tumor Growth by Radiosensitizing Endothelial Cells,” International Journal of Cancer, Vol. 115, No. 2, 2005, pp. 312-319.
doi:10.1002/ijc.20850
|
[19]
|
S. Nasu, K. K. Ang, Z. Fan and L. Milas, “C225 Antiepidermal Growth Factor Receptor Antibody Enhances Tumor Radiocurability,” International Journal of Radiation Oncology Biology Physics, Vol. 51, No. 2, 2001, pp. 474-477.
|
[20]
|
J. P. Condreay and T. A. Kost, “Baculovirus Expression Vectors for Insect and Mammalian Cells,” Current Drug Targets, Vol. 8, No. 10, 2007, pp. 1126-1131.
doi:10.2174/138945007782151351
|
[21]
|
C. Hofmann, V. Sandig, G. Jennings, M. Rudolph, P. Schlag and M. Strauss, “Efficient Gene Transfer into Human Hepatocytes by Baculovirus Vectors,” Proceedings of the National Academy of Sciences of the USA, Vol. 92, 1995, pp. 10099-10103.
doi:10.1073/pnas.92.22.10099
|
[22]
|
T. A. Kost and J. P. Condreay, “Recombinant Baculoviruses as Mammalian Cell Gene-Delivery Vectors,” Trends in Biotechnology, Vol. 20, No. 4, 2002, pp. 173-180.
doi:10.1016/S0167-7799(01)01911-4
|
[23]
|
S. Ghosh, M. K. Parvez, K. Banerjee, S. K. Sarin and S. E. Hasnain, “Baculovirus as Mammalian Cell Expression Vector for Gene Therapy: An Emerging Strategy,” Molecular Therapy, Vol. 6, No. 1, 2002, pp. 5-11.
doi:10.1006/mthe.2000.0643
|